Company: CERO
Filing Date: 2025-11-28
Form Type: DEF 14A
Source: 0001213900-25-115783
Chunk: 59

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-11-28
Form: DEF 14A
Chunk 59
---
olvency of us. If at the time of a conversion the Series C Alternate Conversion Price is determined to be the floor price because such floor price is greater than 80% of the five -dayvolume weighted average price of a share of Common Stock, then the Conversion Amount (as defined in the Certificates of Designations), shall automatically increase such that the shares of Series C Preferred Stock issuable upon such conversion are equal to the number of shares of Common Stock that would have been issuable if the Series C Alternate Conversion Price had been equal to 80% of the volume weighted average price of the Common Stock during the five consecutive trading days immediately prior to such conversion. Other Adjustments.In connection with the private placement, we agreed to seek stockholder approval at a special meeting of stockholders to be held not later than December 15, 2024 of the issuance of Series C Conversion Shares at a conversion price below the Series C Conversion Price (the date of such approval, the “Second Stockholder Approval Date”), which was obtained on November 11, 2024. If, on or after the Second Stockholder Approval Date, we issue any shares of Common Stock for a consideration per share (the “New Issuance Price”) less than a price equal to the Series C Conversion Price in effect immediately prior to such issuance, the Series C Conversion Price shall be reduced to the New Issuance Price. If 30 days or 60 days following the occurrence of the later of (x) the Second Stockholder Approval Date and (y) the earlier of (a) the effective date of the registration statement to be filed pursuant to the Second Registration Rights Agreement and (b) the date that the Series C Preferred Stock is eligible to be resold without restriction under Rule 144 of the Securities Act, the Series C Conversion Price then in effect is greater than the greater of $39.20 and the Market Price (as defined in the Series C Certificate of Designations or Series C Warrants) then in effect (the “Series C Adjustment Price”), the Series C Conversion Price shall automatically lower to the Series C Adjustment Price. 32 As a result of the adjustments described above, as well as the terms of the consent of the holders of the Series C Preferred Stock to permitting the issuance of the Series E Preferred Stock, ranking pari passu thereto, the current Series C Conversion Price is $0.05. Covenants.The Series C Certificate of Designations contains a variety of obligations on our part not to engage in specified activities,